Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Phase 1 trial of tivozanib (AV-951) combined with temsirolimus in patients with renal cell carcinoma 10th International Kidney Cancer Symposium Srinivas, S., Kabbinavar, F. F., Hauke, R. J., Esteves, B., Cotreau, M. M., Strahs, A. L., Fishman, M. N. WILEY-BLACKWELL. 2012: 10–11
View details for Web of Science ID 000303438400023